The impact of two different transfusion strategies on patient immune response during major abdominal surgery: a preliminary report.
Kassiani TheodorakiMaria MarkatouDemetrios RizosArgyro FassoulakiPublished in: Journal of immunology research (2014)
Blood transfusion is associated with well-known risks. We investigated the difference between a restrictive versus a liberal transfusion strategy on the immune response, as expressed by the production of inflammatory mediators, in patients subjected to major abdominal surgery procedures. Fifty-eight patients undergoing major abdominal surgery were randomized preoperatively to either a restrictive transfusion protocol or a liberal transfusion protocol (with transfusion if hemoglobin dropped below 7.7 g dL(-1) or 9.9 g dL(-1), respectively). In a subgroup of 20 patients randomly selected from the original allocation groups, blood was sampled for measurement of IL-6, IL-10, and TNFα. Postoperative levels of IL-10 were higher in the liberal transfusion group on the first postoperative day (49.82 ± 29.07 vs. 15.83 ± 13.22 pg mL(-1), P < 0.05). Peak postoperative IL-10 levels correlated with the units of blood transfused as well as the mean duration of storage and the storage time of the oldest unit transfused (r(2) = 0.38, P = 0.032, r(2) = 0.52, P = 0.007, and r(2) = 0.68, P<0.001, respectively). IL-10 levels were elevated in patients with a more liberal red blood cell transfusion strategy. The strength of the association between anti-inflammatory IL-10 and transfusion variables indicates that IL-10 may be an important factor in transfusion-associated immunomodulation. This trial is registered under ClinicalTrials.gov Identifier: NCT02020525.
Keyphrases
- cardiac surgery
- patients undergoing
- red blood cell
- sickle cell disease
- immune response
- end stage renal disease
- randomized controlled trial
- acute kidney injury
- chronic kidney disease
- newly diagnosed
- ejection fraction
- phase iii
- anti inflammatory
- peritoneal dialysis
- open label
- rheumatoid arthritis
- prognostic factors
- patient reported outcomes
- double blind
- high resolution
- climate change
- placebo controlled